PMC:7556165 / 27721-28843
Annnotations
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T99 | 443-455 | Chemical | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T79 | 1004-1009 | Species | denotes | human | NCBItxid:9606 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T176 | 0-351 | Sentence | denotes | In the last years the ACE2/Ang1–7/MasR system has been intensively studied: physiological effects on cardiomyocytes include modulation of Ca++ signaling and cytokine production, stimulation of cardiomyocytes progenitors and prevention of uncontrolled cell growth (Grobe et al., 2006; Flores-Muñoz et al., 2012; Souza et al., 2013; Chang et al., 2016). |
T177 | 352-599 | Sentence | denotes | Through the Ang1–7 pathway ACE2 produces endothelial antithrombotic effects, vasodilation, nitric oxide release, and inhibits vascular smooth muscle cells (VSMC) proliferation (Loot et al., 2002; Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). |
T178 | 600-787 | Sentence | denotes | In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). |
T179 | 788-1122 | Sentence | denotes | In animal models, Ang1–7 also showed an antiarrhythmic action (Ferreira et al., 2001; Santos et al., 2004; Grobe et al., 2006; Gomes et al., 2010), while compensatory ACE2 upregulation has been observed in explanted human hearts, in patients affected by ischemic or dilated cardiomyopathy (Goulter et al., 2004; Burrell et al., 2005). |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
737 | 22-26 | Gene | denotes | ACE2 | Gene:59272 |
738 | 379-383 | Gene | denotes | ACE2 | Gene:59272 |
739 | 955-959 | Gene | denotes | ACE2 | Gene:59272 |
740 | 34-38 | Gene | denotes | MasR | Gene:116511 |
741 | 1004-1009 | Species | denotes | human | Tax:9606 |
742 | 1021-1029 | Species | denotes | patients | Tax:9606 |
743 | 443-455 | Chemical | denotes | nitric oxide | MESH:D009569 |
744 | 690-712 | Disease | denotes | myocardial hypertrophy | MESH:D006332 |
745 | 760-781 | Disease | denotes | myocardial infarction | MESH:D009203 |
746 | 1042-1050 | Disease | denotes | ischemic | MESH:D007511 |
747 | 1054-1076 | Disease | denotes | dilated cardiomyopathy | MESH:D002311 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T2233 | 22-26 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T2234 | 379-383 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T2235 | 487-493 | Protein | denotes | smooth | https://www.uniprot.org/uniprot/Q9VPM8|https://www.uniprot.org/uniprot/P91682|https://www.uniprot.org/uniprot/B7FNK1 |
T2238 | 955-959 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T76 | 166-176 | http://purl.obolibrary.org/obo/IDO_0000607 | denotes | production |
T77 | 251-255 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
T78 | 256-262 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T79 | 501-506 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T259 | 101-115 | Body_part | denotes | cardiomyocytes | http://purl.org/sig/ont/fma/fma14067 |
T260 | 157-165 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T261 | 193-207 | Body_part | denotes | cardiomyocytes | http://purl.org/sig/ont/fma/fma14067 |
T262 | 251-255 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T263 | 478-506 | Body_part | denotes | vascular smooth muscle cells | http://purl.org/sig/ont/fma/fma284560 |
T264 | 501-506 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T265 | 728-742 | Body_part | denotes | left ventricle | http://purl.org/sig/ont/fma/fma7101 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T62 | 760-781 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T63 | 783-785 | Disease | denotes | MI | http://purl.obolibrary.org/obo/MONDO_0005068 |
T64 | 1054-1076 | Disease | denotes | dilated cardiomyopathy | http://purl.obolibrary.org/obo/MONDO_0005021 |
LitCovid-sample-PD-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 487-500 | http://purl.obolibrary.org/obo/MAT_0000303 | denotes | smooth muscle |
T107 | 494-500 | http://purl.obolibrary.org/obo/MAT_0000025 | denotes | muscle |
T108 | 733-742 | http://purl.obolibrary.org/obo/MAT_0000497 | denotes | ventricle |
T109 | 1010-1016 | http://purl.obolibrary.org/obo/MAT_0000036 | denotes | hearts |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T72 | 143-152 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T73 | 157-176 | http://purl.obolibrary.org/obo/GO_0001816 | denotes | cytokine production |
T74 | 251-262 | http://purl.obolibrary.org/obo/GO_0016049 | denotes | cell growth |
T75 | 256-262 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T76 | 507-527 | http://purl.obolibrary.org/obo/GO_1990874 | denotes | (VSMC) proliferation |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T18 | 760-781 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T19 | 783-785 | Phenotype | denotes | MI | http://purl.obolibrary.org/obo/HP_0001658 |
T20 | 1054-1076 | Phenotype | denotes | dilated cardiomyopathy | http://purl.obolibrary.org/obo/HP_0001644 |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T74 | 143-152 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T75 | 157-176 | http://purl.obolibrary.org/obo/GO_0001816 | denotes | cytokine production |
T76 | 251-262 | http://purl.obolibrary.org/obo/GO_0016049 | denotes | cell growth |
T77 | 256-262 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T78 | 429-441 | http://purl.obolibrary.org/obo/GO_0042311 | denotes | vasodilation |
T79 | 507-527 | http://purl.obolibrary.org/obo/GO_1990874 | denotes | (VSMC) proliferation |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T18 | 760-781 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T19 | 783-785 | Phenotype | denotes | MI | http://purl.obolibrary.org/obo/HP_0001658 |
T20 | 1054-1076 | Phenotype | denotes | dilated cardiomyopathy | http://purl.obolibrary.org/obo/HP_0001644 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
737 | 22-26 | Gene | denotes | ACE2 | Gene:59272 |
738 | 379-383 | Gene | denotes | ACE2 | Gene:59272 |
739 | 955-959 | Gene | denotes | ACE2 | Gene:59272 |
740 | 34-38 | Gene | denotes | MasR | Gene:116511 |
741 | 1004-1009 | Species | denotes | human | Tax:9606 |
742 | 1021-1029 | Species | denotes | patients | Tax:9606 |
743 | 443-455 | Chemical | denotes | nitric oxide | MESH:D009569 |
744 | 690-712 | Disease | denotes | myocardial hypertrophy | MESH:D006332 |
745 | 760-781 | Disease | denotes | myocardial infarction | MESH:D009203 |
746 | 1042-1050 | Disease | denotes | ischemic | MESH:D007511 |
747 | 1054-1076 | Disease | denotes | dilated cardiomyopathy | MESH:D002311 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T176 | 0-351 | Sentence | denotes | In the last years the ACE2/Ang1–7/MasR system has been intensively studied: physiological effects on cardiomyocytes include modulation of Ca++ signaling and cytokine production, stimulation of cardiomyocytes progenitors and prevention of uncontrolled cell growth (Grobe et al., 2006; Flores-Muñoz et al., 2012; Souza et al., 2013; Chang et al., 2016). |
T177 | 352-599 | Sentence | denotes | Through the Ang1–7 pathway ACE2 produces endothelial antithrombotic effects, vasodilation, nitric oxide release, and inhibits vascular smooth muscle cells (VSMC) proliferation (Loot et al., 2002; Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). |
T178 | 600-787 | Sentence | denotes | In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). |
T179 | 788-1122 | Sentence | denotes | In animal models, Ang1–7 also showed an antiarrhythmic action (Ferreira et al., 2001; Santos et al., 2004; Grobe et al., 2006; Gomes et al., 2010), while compensatory ACE2 upregulation has been observed in explanted human hearts, in patients affected by ischemic or dilated cardiomyopathy (Goulter et al., 2004; Burrell et al., 2005). |